Product image of Olimel N9 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin) supplied by GNH India

Olimel N9

Active Ingredient:
Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin
Origin:
EU

Olimel N9 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N9, is a mixture of essential and non-essential amino acids presented as a sterile powder for intravenous use. It is intended for clinical nutrition support in patients requiring parenteral amino acid supplementation.

GNH India supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Manufacturer / TM Owner

Baxter Oy

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Olimel N9 provides a comprehensive amino acid profile for patients who need intravenous nutritional support. It is used in the following clinical situations:

  • Post‑operative recovery: Helps to restore nitrogen balance and support tissue repair.
  • Critical illness or severe trauma: Supplies essential amino acids when oral intake is insufficient.
  • Long‑term parenteral nutrition: Maintains protein synthesis and prevents muscle wasting.

How It Works

  • The formulation delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream, bypassing gastrointestinal absorption. These amino acids serve as substrates for protein synthesis, support nitrogen balance, and act as precursors for neurotransmitters and metabolic intermediates, thereby facilitating tissue repair and metabolic stability.

Side Effects

Adverse reactions reported with intravenous amino‑acid mixtures are generally related to the infusion process and individual sensitivity.

Common Side Effects

  • Mild fever or chills during infusion.
  • Transient erythema or irritation at the IV site.
  • Nausea or mild gastrointestinal discomfort.
  • Headache.
  • Elevated serum potassium levels.
  • Slight increase in blood urea nitrogen.

Serious or Rare Side Effects

  • Anaphylactic or severe hypersensitivity reaction.
  • Acute metabolic acidosis.
  • Hyperammonemia.
  • Thrombophlebitis at the infusion site.
  • Severe electrolyte disturbances.
  • Renal impairment in susceptible patients.

Precautions & Warnings

When using Olimel N9, clinicians should consider the following precautions:

  • Assess renal function: Adjust dosing in patients with impaired kidney function.
  • Monitor electrolytes: Regularly check serum electrolytes and acid‑base status.
  • Evaluate nitrogen balance: Ensure appropriate protein intake to avoid overload.
  • Observe infusion site: Watch for signs of phlebitis or infiltration.
  • Review concomitant nutrition: Coordinate with total parenteral nutrition regimens to prevent excess amino acids.
  • Store at ambient temperature: Keep in original packaging, protect from moisture and direct light.

Avoid Interactions

Intravenous amino‑acid solutions may interact with other medications administered concurrently.

Major Interactions (Avoid)

  • High‑dose potassium supplements: May exacerbate hyperkalemia.
  • Acidifying agents (e.g., ammonium chloride): Increase risk of metabolic acidosis.
  • Certain antibiotics antibiotics: May precipitate when mixed in the same bag.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: Can alter electrolyte balance.
  • Insulin therapy: May enhance intracellular potassium shift.
  • Anticoagulants: May require dose adjustment due to changes in plasma protein binding.

Frequently Asked Questions

Olimel N9 is an intravenous amino‑acid mixture used to provide nutritional support for patients who cannot receive adequate protein through oral or enteral routes. It is commonly employed in postoperative care, critical‑illness management, and long‑term parenteral nutrition programs.

The blend supplies essential and non‑essential amino acids directly into the bloodstream, supplying the building blocks needed for protein synthesis, nitrogen balance, and metabolic functions. These amino acids also act as precursors for neurotransmitters and other biologically active molecules.

Dosing is individualized and determined by the prescribing clinician based on the patient’s weight, renal function, overall nutritional needs, and the composition of any concurrent parenteral nutrition regimen.

Safety data for intravenous amino‑acid mixtures in pregnancy and lactation are limited. Use is generally reserved for situations where the benefit to the mother outweighs potential risks to the fetus or infant, and it should be prescribed by a specialist.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Olimel N9 offers a balanced profile of ten amino acids that matches many standard amino‑acid formulations used in parenteral nutrition. Compared with products that contain a broader spectrum of amino acids, Olimel N9 may be selected for specific clinical protocols or when a simpler formulation is preferred.

Store the product at ambient temperature, protected from moisture and direct light, in its original packaging. Follow aseptic technique during reconstitution and infusion, and discard any unused solution after the recommended infusion period.

Olimel N9 is supplied as a sterile powder that is reconstituted with a compatible diluent and administered intravenously, typically as part of a total parenteral nutrition bag or as a separate infusion, under the supervision of qualified healthcare professionals.

Serious risks include severe hypersensitivity reactions, metabolic acidosis, hyperammonemia, and significant electrolyte disturbances. Patients should be closely monitored for signs of these events, especially during the initial infusion period.

Patients with known hypersensitivity to any component of the amino‑acid mixture, uncontrolled hyperkalemia, severe metabolic acidosis, or those with contraindications to parenteral nutrition should not receive Olimel N?.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.